ipsapirone
Ipsapirone is a psychoactive drug that acts as a partial agonist at the 5-HT1A serotonin receptor. It belongs to the azapirone class of compounds and was developed as a potential anxiolytic and antidepressant medication. Unlike benzodiazepines, which enhance the effects of GABA, ipsapirone's mechanism of action involves the modulation of serotonin neurotransmission.
Clinical studies have investigated ipsapirone for its effects on anxiety disorders and depression. Its anxiolytic properties
Ipsapirone is orally administered and undergoes metabolism in the liver. Its pharmacokinetic properties have been studied